Attenuated Psychosis Syndrome
Resources for Patients and Caregivers
The DSM-5 has listed attenuated psychosis syndrome (APS) as a “condition for future study.” APS can involve mild delusions, hallucinations, and disorganized speech, with relatively intact reality testing in the absence of a clear psychotic disorder, and has been thought to be a risk state for later schizophrenia
Cluster Number:
Wiki Number: 07-Attenuated Psychosis Syndrome
Diagnosis: Lower levels of psychotic symptoms-such as low-intensity hallucinations
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms:
Progression:
Causes:
Medications:
Therapies:
Youtube Video: The 3 Traits of Psychosis
Amazon or Library Book:
Handbook of Attenuated Psychosis Syndrome Across Cultures
Click the book to link or order from Amazon.
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Longitudinal Trajectories of Premorbid Social and Academic Adjustment in Youth at Clinical High Risk for Psychosis: Implications for Conversionby Henry R Cowan on May 6, 2024
CONCLUSIONS: Premorbid social function is an important factor in risk for conversion to psychosis. Negative symptoms and childhood trauma had different relationships to premorbid functioning in converters vs non-converters. Mechanisms linking symptoms and trauma to functional impairment may be different in converters vs non-converters, suggesting possible new avenues for risk assessment.
- Psychopathological characteristics in ultra-high risk for psychosis with and without comorbid ADHDby Michele Ribolsi on May 1, 2024
CONCLUSIONS: The different profiles of negative symptoms in the APS with or without ADHD might suggest the presence of a specific subtype among individuals at ultra-high risk for psychosis. Longitudinal studies with larger samples will provide information about the role of negative symptoms in determining conversion to full psychosis in those people with 'pure' APS and those with APS + ADHD.
- Staging 2·0: refining transdiagnostic clinical staging frameworks to enhance reliability and utility for youth mental healthby Jan Scott on April 21, 2024
Globally, 75% of depressive, bipolar, and psychotic disorders emerge by age 25 years. However, these disorders are often preceded by non-specific symptoms or attenuated clinical syndromes. Difficulties in determining optimal treatment interventions for these emerging mental disorders, and uncertainties about accounting for co-occurring psychopathology and illness trajectories, have led many youth mental health services to adopt transdiagnostic clinical staging frameworks. In this Health Policy...
- Nomenclature for psychosis risk in Japan: Survey results from high-risk individuals, caregivers, and mental health professionalsby Tsutomu Takahashi on April 17, 2024
CONCLUSION: The term ARMS-kokoro was commonly accepted as a favorable labeling term for the high-risk state for psychosis in Japan. However, another translation ARMS-psychosis was considered stigmatizing, demonstrating the importance of appropriate translation of high-risk terminology into local languages.